Top
Healthcare News | Public Healthcare
National Shortage of Verorab™ Rabies Vaccine: Chirorab® Now Available as an Alternative Boost
Time to read: 00:57
Published: 3 May 2025
Healthcare professionals are advised that the dosing schedule for Chirorab® remains consistent with existing national and World Health Organization (WHO) guidelines for both pre- and post-exposure prophylaxis. While the volume per vial differs between Chirorab® and Verorab™, each vial of Chirorab® still constitutes a single intramuscular dose.
Public-sector healthcare facilities requiring a supply of Chirorab® should contact their relevant provincial pharmacy depots for procurement. Providers in the private sector are encouraged to follow procurement protocols as per their internal organisational procedures.
This article was compiled with information obtained from various sources including:
22 April 2025 | NICD | Rabies Prevention and Vaccine Update: Chirorab® Now Available in South Africa
Disclaimer
This article is compiled from various resources researched and compiled by the contributor. It is in no way presented as an original work. Every effort has been made to correctly attribute quotes and content. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us
Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.
